Dergi
/
Kimya
/
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
JoVE Journal
Kimya
Bu içeriği görüntülemek için JoVE aboneliği gereklidir.  Oturum açın veya ücretsiz deneme sürümünü başlatın.
JoVE Journal Kimya
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

12,752 Views

•

10:44 min

•

May 15, 2019

DOI:

10.3791/59472-v

DOI:
10.3791/59472-v

•

10:44 min
May 15, 2019

•

17 Views
, , , , ,
1Department of Internal Medicine III,University Hospital Ulm, 2Pharmaceutical Institute, Pharmaceutical Chemistry I,University of Bonn

Özet

Automatically generated

This work describes the synthesis and characterization of a pomalidomide-based, bifunctional homo-PROTAC as a novel approach to induce ubiquitination and degradation of the E3 ubiquitin ligase cereblon (CRBN), the target of thalidomide analogs.

Explore More Videos

CRBN InhibitionPROTACPomalidomideCereblonE3 Ubiquitin LigaseProtein DegradationChemical SynthesisGlutarimide3-fluorophthalic AnhydrideDiamine Linker

Read Article

Cite this Article

Lindner, S., Steinebach, C., Kehm, H., Mangold, M., Gütschow, M., Krönke, J. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs. J. Vis. Exp. (147), e59472, doi:10.3791/59472 (2019).

Download .ris file

Copy

Share Video

.

Copy